{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/0781-3117#drug","name":"Piperacillin and Tazobactam","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0781-3117"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA203557"},{"@type":"PropertyValue","propertyID":"UNII","value":"UXA545ABTT|M98T69Q7HP"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"b1cb1314-d3e0-4b44-a1df-de14c32e8cc6"}],"activeIngredient":"PIPERACILLIN SODIUM, TAZOBACTAM SODIUM","administrationRoute":["INTRAVENOUS","PARENTERAL"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Sandoz Inc"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/ANDA203557","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1cb1314-d3e0-4b44-a1df-de14c32e8cc6","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-3117"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-27T08:58:37.324Z"}}